Liposome composition for improved intracellular delivery of a therapeutic agent
Details for Australian Patent Application No. 2002305094 (hide)
International Classifications
Event Publications
19 December 2002 Complete Application Filed
Priority application(s): 60/278,869 26.03.01 US
27 March 2003 Application Open to Public Inspection
Published as AU-B-2002305094
11 January 2007 Application Accepted
Published as AU-B-2002305094
8 March 2007 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 09 Feb 2007. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000
24 May 2007 Standard Patent Sealed
2 August 2007 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 09 Feb 2007
22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002305095-RAKE RECEIVER WITH EMBEDDED DECISION FEEDBACK EQUALIZER
2002305093-METHODS FOR DIAGNOSING AND TREATING MULTIPLE SCLEROSIS AND COMPOSITIONS THEREOF
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser